To da te, only 22 cases of nasoph aryngeal cyst of branchiogenic origin have been reported in the literature. In this article, we report a new case in a 35-year-old woman . We also present a review of the literatu re and a discussion of the sites of origin, histopathology, and treatment modalities.
breathin g, and a per sistent right nasal discharge of 5 months' duration . She also reparted a 4-month history of decreased hearing and pain in the right ear . Examination revealed a well-circumscribed yellowish mass in the nasopharynx (figure 1). The mass was covered with mucous membrane and dilated blood vesse is and was attached to the posterolateral aspect of the nasopharynx on the right side. It extended from the roof of the nasopharynx superiorly to the middle of the right tonsil inferiorly. Medially, the mass crossed the midline; later-aIly, it was attached to the laterai nasopharyngeal wall posteriar to the posterior pillar of the tonsil.
On palpation, the mass was cystic in its consistency. Examination of the right ear revea led a dull and retract ed tymp anic memb rane. Findin gs on the rem ainder of the examination were norm al. Computed tomography (CT) of the nasopharynx showed that a well-circ umscribed low-d ensity mass 3 cm in diameter was attac hed to the posterior and laterai walls of the nasopharynx on the right side (figure 2). There was no bony erosion. On audiologic investigation, the patient had a conductive hearing loss of 15 dB on the right and a flat tympanogram.
Aspiration of the eyst yielded white opaque material. The 5 x 5-cm cyst was excise d under general anesthesia via a transoral approach. Histopathology revealed a branchial cyst lined with stratified squamous epithelium. A submucosa l layer contained Iymphoid follicles, mononuclear inflammatory eelis, and goblet eelis (figures 3 and 4). There was no recurrence after 3 years of followup.
Discussion
Most reports of nasopharyngeal cysts of branchial origi n have been either one-or two-patient studies. Fifteen of the 22 cases involved males. Patients' ages ranged from 2 to 69 years; the most common age range was 52 to 59 years, accounting for eight of the 22 cases.
Sites oforigin. In the 22 previously reported cases, 12
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For mare information Clrcle 132 on Reader Service Card VERMA, SO HAlL, AL-KHABORI, MOOSA involved only the right side of the nasopharynx. Four patients had a cyst only on the left side , four had bilateral disease , one had a cys t at the midline, and one was unreported.
All cysts but one were located in relation with the upper part of the posterior piIIar of the tons iI. In light of this finding, it is presumed that these cysts usualIy arise from the second branchial arch, and they are classified as type IV cysts according to Proctor' s cIassification (table 2) . 1 5 Nasopharyngeal cysts of branchial origin can develop at any point along an imagin ary line drawn from the upper pole of the tonsi l and behind the eust achian tube orifice (the so-calIed lower-Ievel cysts) and along RosenmülIer's fossa and mediaIly and slightly forward of the midline of the nasopha ryngeal vault (upper-Ievel cysts) .
Because the cyst in our patient was attached to the lateral nasoph aryngeal wall and extended from the middle of the tonsil to the roof of the nasopharynx, it was cIassified as a lower-Ievel lesion.
Histopathology. In 12 of the 22 previously reported cases, the mucous membrane was lined with either stratified/pseudostratified ciliated columnar epithelium or ciIiated columnar epithelium . In three patients, the lining mucou s membrane was either columnar or stratified columnar epithelium. Four patients had a stratified squamous epithelium. In one patient, the cyst was lined with squamous and transition al epithelia and contained Iymphoid foIIicles in the subepithelial plane . There was no 726 mention of histology in the repor ts of the remaining two patients . In all, seven of these cysts featured subepithelial Iymphoid aggregation.
The preci se embryologic pathogenesis of pharyngeal cysts of branchial origin is not weIl under stood. The difference in epithelial linings (respiratory or squamous) and the presence of Iymphoid tissue in the subep ithelial plane make it diffic ult to determine whether these cysts are endo -or ectodermaI. Several theories have been propesed. According to the branchial apparatus theory, type IV cysts arise from a remnant of an intern aI pharyn-geaI duct, which would indic ate that they are endoder-maI. 16 On the other hand, seven cysts reported in the literature in addition to the one in our patient featured Iymphoid follicle s in the cyst wall, while in four other patients the cyst was lined with stratified squamous epithelium; these elements suggest an ectoderm aI origin. RatHepatocyte DNA Repair Assay MieronucleusTest (Miee) Dominant LethalTest (Mice) Long-term earei nogenicitystudiesin mieeand rats have been eompleted for eiprofloxaein. After daily oral doses of 750 mg/kg (miee) and 250 mg/kg (rats) were administered for up to 2 years, therewas noevidenee thateiprofloxaein had any earei nogenie or tumor lgenle etteets in these species. Nolong term studies of CIPRO' HCOTIC suspension havebeen performed to evaluate eareinogeniepotential. Fertility studiesperformed in ratsat oral doses of elprofloxaeln upto 100mg/kg/day revealed no evidenee of impairment. Thi s would be over1000 times the maximum reeommended eliniealdose of ototopleal eiprofloxaein based upon body surfaee area, assuming total absorption of clprotloxaclnfrom theear of a patient treated withCIPRO' HC OTIC twiceperday. Long term studies have not been performed to evaluatethe eareinogeniepotent ial or theeff eeton fert ility oftopieal hydroeortisone. Mutageni eity studies with hydro eorti sonewerenegative. Pregnaney: Teralogenlc Effecls. Pregnancy Calegory C: Reproductionstudies havebeen perf ormed in ratsand mi eeusing oral doses ofupto 100 mglkgand iVdosesupto30mglkgandhave reveai ed noevideneeof harm tothe fetus asaresult ofciprofloxaein. Inrabbits, clprotloxacln (30and 100mglkgorally)produeed gastrointestinal di sturbances result ingin maternaiweight lossand an inereased incideneeofabortion, butnoteratogenici ty was observed at eit her dose. After intravenousadmi nistrat ion of doses upto 20mglkg, nomaternaitoxiei tywas produeed intherabbit,and noembryotoxieityor teratoqenlcltywas observed. Cortieosteroidsaregenerall y teratogeniein laboratoryanimals when admi nistered systemicallyatrelatively low dosage levei s.The more potent eorticosteroids have beenshownto beteratog enic after dermaiapplieation inlaboratoryanirnaIs. Animalreprodu ctionstudies have not beenconducted with CIPRO' HC OTIC. No adequateand weil controlled studiesnave been performedin pregnantwomen. Caution should be exerei sed when CIPRO' HC OTIC is used byapregnantwoman. Nurslng Mothers: Ciprofloxacin is excreted in human milkwith systemie use. It is not known whether ciprotloxacin is exereted in humanmilk following topieal otieadministration. Seeauseof thepotent ialforseriousadverse reaeti ons in nursing lntant s, aceclslon shouIdbemadewhether to discont inuenursing or to discontinuethe drug, taking into aecount the importanee of thedrug to themother . Pedlalrlc use: The satety and efficacy of CIPRO' HCOTiC have been established in pediatrie patient s 2 yearsand older (131 pati ent s) inadequateandwell-eontrolled elinicaltrial s.Although no data areavail able on patient s less thanage 2 years, thereareno known safety concerns or differeneesinthediseaseprocess inthis population whiehwould preclude useof thi s productinpati ents Wild et al postulated that these eysts are deri ved from eetopie epit heiial eells in the regional Iymph nodes and are therefore ectodermal.'?
Alcari
PHARMACEUTICALS
Treatment. Different treatment modalities have been used. Of the 22 patient s, 18 unde rwent surgi eal exeision. Two patients underwent aspir ation only, and two others were treated with aspiration pius injeetion of 1 mi of a 5% aqueo us solution of ethanolamine oleate as a seleros ing agent. There were no reports of any reeurrenee. The transoral surgieal approae h provides better aecess to eysts at the lower level," :" whereas the transpalatal approaeh is better for eysts at the upper level. 13 Tamagawa et al, who performed the endonasal removal, reeomm end this proeedure over the transpal atal approaeh beeause it is less invasive and maint ains the normal anatomy of the palate."
In our patient, we were able to exeise the eyst transarall y und er direet vision. We bel iev e that thi s eyst was branehiogenie in origin and that it arose from the second branehial areh at the lower level. For more info rmation Circle 121 on Reader Service Card
